DLL1 and breast neoplasm: The tumor promoting function of DLL1 in ERα+ luminal breast tumors was initiated by estrogen-mediated inhibition of DLL1 ubiquitination and degradation, leading to increase in DLL1 protein stability (Kumar et al., 2019).